SlideShare a Scribd company logo
Dissolution
Model
Presented by- Rajdeepa Kundu(JISU/2022/0198)
Batch-M.Pharm 1st year Pharmaceutics
Under the guidance of – Dr Tapan Kumar Shaw
(Associate professor of JIS university)
Dissolution
• According to the IUPAC,the term
“dissolution” is defined as “The mixing of
two phases with the formation of one new
homogeneous phase (i.e. the solution).”
• The “dissolution rate” of a drug in a
liquid is generally defined as the change in
the concentration of dissolved drug
(individualized drug
molecules/ions/atoms), dc, in the time
interval dt:
• dissolution rate = dc/ dt
5 major steps involved in the dissolution of solid
drug particles in a well-stirred aqueous medium
• The surface of the drug particle is wetted with water.
• (b) Solid-state bonds in the drug particle are broken down (e.g. attractive
electrostatic forces in a drug crystal consisting of cations and anions).
• (c) Individualized drug molecules/ions/atoms are surrounded by a shell of water
molecules (“solvation”). (d) The individualized drug molecules/ions/atoms diffuse from
the surface of the drug particle through the liquid, unstirred boundary layer surrounding
the system into the well-stirred bulk fluid. It has to be pointed out that even in
thoroughly stirred aqueous liquids thin unstirred boundary layers exist directly at the
surfaces of the drug particles (due to adhesional forces). The thickness of these
boundary layers is a function of the degree of agitation.
• (e) If the surrounding bulk fluid is well-stirred, the drug molecules/ions/atoms are
transported by convection in the liquid, which is not part of the unstirred boundary
layer: The mass flow created by stirring assures rapid movement of water and
Modeling of dissolution profiles
A water-soluble drug incorporated in a matrix is
mainly released by diffusion, while for a low
water-soluble drug the self-erosion of the matrix
will be the principal release mechanism.
• To accomplish these studies the cumulative
profiles of the dissolved drug are more
commonly used.
• To compare dissolution profiles between two
drug products model dependent (curve fitting),
statistic analysis and model independent
methods can be used.
Mathematical models:
• Zero order kinetics
• First-order kinetics
• Weibull model
• Higuchi model
• Hixson–Crowell model
• Korsmeyer–Peppas model
• Baker–Lonsdale model
• Hopfenberg model
• Other release parameters
Zero-order
kinetics
Drug dissolution from pharmaceutical dosage forms that do not
disaggregate and release the drug slowly (assuming that area
does not change and no equilibrium conditions are obtained) can be
represented by the following equation.
The pharmaceutical dosage forms following this profiles release the
same amount of drug by unit of time and it is the ideal method of
drug release in order to achieve a pharmacological prolonged
action.
• W0 – Wt = Kt , where W0 is the initial amount of drug in the
pharmaceutical dosage form, Wt is the amount of drug dissolved at
time t and K is a proportionality constant.
Applications: This relation can be used to describe the drug
dissolution of several types of modified release pharmaceutical
dosage forms, as in the case of some transdermal systems, as
well as matrix tablets with low soluble drugs, coated forms,
osmotic systems, etc
First-order
kinetics
This model was first proposed by Gibaldi and Feldman (1967) and
later by Wagner (1969).
The dissolution phenomena of a solid particle in a liquid media
implies a surface action, as can be seen by Noyes–Whitney
Equation: dC/dt = K(Cs –C),where C is the concentration of the
solute in time t, Cs is the solubility and K is a first order
proportionality constant.
This equation was altered by Brunner et al. (1900), to incorporate
the value of the solid area accessible to dissolution, S, getting:
dC/dt = K1 S(Cs-C), Where, k1 is a new proportionality constant.
Using the Fick first law, it is possible to establish the following
relation ,for the constant k1 = D/Vh , where D is the solute diffusion
coefficient in the dissolution media, V is the liquid dissolution
volume and h is the width of the diffusion layer.
Continue…
Hixson and Crowell adapted the Noyes–Whitney equation in the following manner:
dW/dt = kS(Cs-C), where W is the amount of solute in solution at time t, dW/dt is the
passage rate of the solute into solution in time t and K is a constant.
This last equation is obtained from the Noyes–Whitney equation by multiplying both
terms of equation by V and making K equal to k V. Comparing these terms, the following
relation is obtained: • K= D/h
In this manner, Hixson and Crowell equation can be written as:dW/ dt = KS/V (VCs-W) =
k (VCs-W),Where k = k1S.
If one pharmaceutical dosage form with constant area is studied in ideal conditions (sink
conditions), it is possible to use this last equation that, after integration, will become: W =
VCs (1 – e -kt) .This equation can be transformed, applying decimal logarithms in both
terms, into: Log (VCs- W) = log VCs- (kt/2.303), The data obtained are plotted as log
cumulative percentage of drug remaining vs. time which would yield a straight line with a
slope of-K/2.303
Applications: This relationship can be used to describe drug dissolution in
pharmaceutical dosage forms such as those containing water-soluble drugs in porous
matrices.
Hixson–
Crowell
model
Drug powder that having uniformed size particles, Hixson and Crowell derived the
equation which expresses rate of dissolution based on cube root of weight of
particles and the radius of particle is not assumed to be constant.
This is expressed by the equation, M0 1/3 - Mt 1/3 = κ t ,Where, M0 is the initial
amount of drug in the pharmaceutical dosage form, Mt is remaining amount of drug
in the pharmaceutical dosage form at time ‘t’ and κ is proportionality constant.
To study the release kinetics, data obtained from in vitro drug release studies were
plotted as cube root of drug percentage remaining in matrix versus time
Applications: This applies to different pharmaceutical dosage forms such as
tablets, where the dissolution occurs in planes parallel to the drug surface if the
tablet dimensions diminish proportionally, in such a way that the initial geometrical
form keeps constant all the time.
Cube root law- The dissolution data are plotted in accordance with the
Hixson-Crowell cube root law, i.e. the cube root of the initial concentration
minus the cube root of per cent remained, as a function of time. The results
indicates that a linear relationship was obtained in all cases.
Higuchi model
This is the first mathematical model that describes drug release from a matrix system, proposed
by Higuchi in 1961.
This model is based on the different hypotheses that (1) Initial drug concentration in the matrix is
much higher than drug solubility, (2) Drug diffusion takes place only in one dimension (Edge
effect should be avoided), (3) Drug particles are much smaller than thickness of system, (4)
swelling of matrix and dissolution are less or negligible, (5) Drug diffusivity is constant, (6)
Perfect sink condition is always attained in the release environment.
Equation-ft = Q = √D(2C-Cs )Cs t , where Q is the amount of drug released in time t per unit
area, C is the drug initial concentration, Cs is the drug solubility in the matrix media and D is the
diffusivity of the drug molecules (diffusion constant) in the matrix substance.
Higuchi describes drug release as a diffusion process based in Fick’s law, square root time
dependent. The data obtained were plotted as cumulative percentage drug release versus
square root of time
Applications: This relationship can be used to describe the drug dissolution from several types
of modified-release pharmaceutical dosage forms, as in the case of some transdermal systems
and matrix tablets with water-soluble drugs.
Korsmeyer–
Peppas
model
Nicholas Peppas was the first to introduce this equation in the field of drug delivery
(Peppas, 1985).
Clearly, the classical Higuchi equation as well as the above-described short time
approximation of the exact solution of Fick’s second law for thin films with initial drug
concentrations, which are below drug solubility (monolithic solutions)
Frequently used and easy-to-apply model to describe drug release Peppas equation, or
power law: Mt/M∞= kt n , Here, Mt and M∞ are the absolute cumulative amount of drug
released at time t and infinite time, respectively; k is a constant incorporating structural and
geometric characteristics of the system, and n is the release exponent, which might be
indicative of the mechanism of drug release.
Used when a release exponent of 0.5 can serve as an indication for diffusion-controlled
assumptions drug release, but only if all these particular solutions are based on are
fulfilled, for example film geometry with negligible edge effects, time- and position-
independent diffusion coefficients in a non-swellable and insoluble matrix former
Applications: This equation has been used to the linearization of release data from
several formulations of microcapsules or microspheres.
Comparison of dissolution
profiles
The drug-release profiles can be analyzed using the f2 metrics
mathematical equation that compares drug-release curves.
• f2 metric is the similarity factor, and values of f2 between 50 and
100 suggest profile similarity. A value less than 50 represents a
significant difference and equates to a greater than 10% dissolved
difference between the two drug-release curves.
• Rt represents the reference profile, Tt represents the test profile
where (n) is the number of data points collected.
Equation:
Difference
factor(F1)
Similarity
factor(F2)
innference
0 100 Dissolution
profile are
similar
<=15 50 Similarity
or
equivalenc
e of 2
profile
Reference
Cartensen JT; Modeling and data treatment
in the pharmaceutical sciences. Technomic
Publishing Co. Inc., New York, Basel
1996
Ramteke KH, Dighe PA, Kharat AR, Patil
SV. Mathematical models of drug
dissolution: a review. Sch. Acad. J. Pharm.
2014 Jan;3(5):388-96.
2014
Thank you.

More Related Content

What's hot

Higuchi And Peppas Plot
Higuchi And Peppas PlotHiguchi And Peppas Plot
Higuchi And Peppas Plot
SimranDhiman12
 
Concept of optimization Optimization parameters.pptx
Concept of optimization Optimization parameters.pptxConcept of optimization Optimization parameters.pptx
Concept of optimization Optimization parameters.pptx
Himadri priya Gogoi
 
Technology Transfer From R and D to Pilot Plant to Plant for Non-Sterile Semi...
Technology Transfer From R and D to Pilot Plant to Plant for Non-Sterile Semi...Technology Transfer From R and D to Pilot Plant to Plant for Non-Sterile Semi...
Technology Transfer From R and D to Pilot Plant to Plant for Non-Sterile Semi...
shiv
 
Process validation of tablet compression
Process validation of tablet compressionProcess validation of tablet compression
Process validation of tablet compression
Sanket Shinde
 
Validation of tablets and sterile products
Validation of tablets and sterile productsValidation of tablets and sterile products
Validation of tablets and sterile products
vansh raina
 
Solid state stability and shelf-life assignment, Stability protocols,reports ...
Solid state stability and shelf-life assignment, Stability protocols,reports ...Solid state stability and shelf-life assignment, Stability protocols,reports ...
Solid state stability and shelf-life assignment, Stability protocols,reports ...
Durga Bhavani
 
201p
201p201p
permeability in vivo in vitro in situ.pptx
permeability in vivo in vitro in situ.pptxpermeability in vivo in vitro in situ.pptx
permeability in vivo in vitro in situ.pptx
anumalagundam sreekanth
 
selection of dissolution medium And dissolution study of solid dosage form
selection of dissolution medium And dissolution study of solid dosage formselection of dissolution medium And dissolution study of solid dosage form
selection of dissolution medium And dissolution study of solid dosage form
Ashwin Patil
 
M pharm dissolution
M pharm dissolutionM pharm dissolution
M pharm dissolution
Malla Reddy College of Pharmacy
 
Coating technology m.pharmacy 1st year
Coating technology m.pharmacy 1st yearCoating technology m.pharmacy 1st year
Coating technology m.pharmacy 1st year
priyankapatil7896
 
alternative methods for dissolution.pptx
alternative methods for dissolution.pptxalternative methods for dissolution.pptx
alternative methods for dissolution.pptx
anumalagundam sreekanth
 
Dissolution parameters
Dissolution parametersDissolution parameters
Compendial methods of dissolution
Compendial methods of dissolutionCompendial methods of dissolution
Compendial methods of dissolution
Hemanth KG
 
mathematical models for drug release studies
mathematical models for drug release studiesmathematical models for drug release studies
mathematical models for drug release studies
SR drug laboratories
 
Small volume parenterals
Small volume parenteralsSmall volume parenterals
drug dissolution
drug dissolutiondrug dissolution
CO–PROCESSED EXCIPIENTS FOR TABLETS.pdf
CO–PROCESSED EXCIPIENTS FOR TABLETS.pdfCO–PROCESSED EXCIPIENTS FOR TABLETS.pdf
CO–PROCESSED EXCIPIENTS FOR TABLETS.pdf
Yamini Shah
 
Microcapsules: types, preparation and evaluation
Microcapsules: types, preparation and evaluationMicrocapsules: types, preparation and evaluation
Microcapsules: types, preparation and evaluation
MOHAMMAD ASIM
 
consoliation
consoliationconsoliation
consoliation
PV. Viji
 

What's hot (20)

Higuchi And Peppas Plot
Higuchi And Peppas PlotHiguchi And Peppas Plot
Higuchi And Peppas Plot
 
Concept of optimization Optimization parameters.pptx
Concept of optimization Optimization parameters.pptxConcept of optimization Optimization parameters.pptx
Concept of optimization Optimization parameters.pptx
 
Technology Transfer From R and D to Pilot Plant to Plant for Non-Sterile Semi...
Technology Transfer From R and D to Pilot Plant to Plant for Non-Sterile Semi...Technology Transfer From R and D to Pilot Plant to Plant for Non-Sterile Semi...
Technology Transfer From R and D to Pilot Plant to Plant for Non-Sterile Semi...
 
Process validation of tablet compression
Process validation of tablet compressionProcess validation of tablet compression
Process validation of tablet compression
 
Validation of tablets and sterile products
Validation of tablets and sterile productsValidation of tablets and sterile products
Validation of tablets and sterile products
 
Solid state stability and shelf-life assignment, Stability protocols,reports ...
Solid state stability and shelf-life assignment, Stability protocols,reports ...Solid state stability and shelf-life assignment, Stability protocols,reports ...
Solid state stability and shelf-life assignment, Stability protocols,reports ...
 
201p
201p201p
201p
 
permeability in vivo in vitro in situ.pptx
permeability in vivo in vitro in situ.pptxpermeability in vivo in vitro in situ.pptx
permeability in vivo in vitro in situ.pptx
 
selection of dissolution medium And dissolution study of solid dosage form
selection of dissolution medium And dissolution study of solid dosage formselection of dissolution medium And dissolution study of solid dosage form
selection of dissolution medium And dissolution study of solid dosage form
 
M pharm dissolution
M pharm dissolutionM pharm dissolution
M pharm dissolution
 
Coating technology m.pharmacy 1st year
Coating technology m.pharmacy 1st yearCoating technology m.pharmacy 1st year
Coating technology m.pharmacy 1st year
 
alternative methods for dissolution.pptx
alternative methods for dissolution.pptxalternative methods for dissolution.pptx
alternative methods for dissolution.pptx
 
Dissolution parameters
Dissolution parametersDissolution parameters
Dissolution parameters
 
Compendial methods of dissolution
Compendial methods of dissolutionCompendial methods of dissolution
Compendial methods of dissolution
 
mathematical models for drug release studies
mathematical models for drug release studiesmathematical models for drug release studies
mathematical models for drug release studies
 
Small volume parenterals
Small volume parenteralsSmall volume parenterals
Small volume parenterals
 
drug dissolution
drug dissolutiondrug dissolution
drug dissolution
 
CO–PROCESSED EXCIPIENTS FOR TABLETS.pdf
CO–PROCESSED EXCIPIENTS FOR TABLETS.pdfCO–PROCESSED EXCIPIENTS FOR TABLETS.pdf
CO–PROCESSED EXCIPIENTS FOR TABLETS.pdf
 
Microcapsules: types, preparation and evaluation
Microcapsules: types, preparation and evaluationMicrocapsules: types, preparation and evaluation
Microcapsules: types, preparation and evaluation
 
consoliation
consoliationconsoliation
consoliation
 

Similar to Dissolution model.pptx

Modeling and comparison of dissolution profiles - Review by Paulo Costa*, Jos...
Modeling and comparison of dissolution profiles - Review by Paulo Costa*, Jos...Modeling and comparison of dissolution profiles - Review by Paulo Costa*, Jos...
Modeling and comparison of dissolution profiles - Review by Paulo Costa*, Jos...
MAHENDRA PRATAP SWAIN
 
Consolidation parameters
Consolidation parametersConsolidation parameters
Consolidation parameters
Surbhi Narang
 
DRUG RELEASE KINETICS AND MATHEMATICAL MODELLING.pptx
DRUG RELEASE KINETICS AND MATHEMATICAL MODELLING.pptxDRUG RELEASE KINETICS AND MATHEMATICAL MODELLING.pptx
DRUG RELEASE KINETICS AND MATHEMATICAL MODELLING.pptx
Dipti Nigam
 
Consolidation parameters
Consolidation parametersConsolidation parameters
Consolidation parameters
PawanYadav285
 
Dissolution models (sem 1)
Dissolution models (sem 1)Dissolution models (sem 1)
Dissolution models (sem 1)
HARSHALA DHENDE
 
DISSOLUTION AND MECHANISM OF DRUG RELEASE
 DISSOLUTION AND MECHANISM OF DRUG RELEASE DISSOLUTION AND MECHANISM OF DRUG RELEASE
DISSOLUTION AND MECHANISM OF DRUG RELEASE
Ashish Kumar Mishra
 
Consolidation parameter
Consolidation parameterConsolidation parameter
Consolidation parameter
Kahnu charan panigrahi
 
Consolidation parameter
Consolidation parameterConsolidation parameter
Consolidation parameter
Kahnu charan panigrahi
 
invito release models.pptx
invito release models.pptxinvito release models.pptx
invito release models.pptx
MehreenFarooq3
 
Kinetic models
Kinetic modelsKinetic models
Kinetic models
Ritesh Ghate
 
Dissolution kinetics and dissolutition modesl
Dissolution kinetics and dissolutition modeslDissolution kinetics and dissolutition modesl
Dissolution kinetics and dissolutition modesl
sagar Aher
 
effect of system parameters on controlled release drug delivery
effect of system parameters on controlled release drug deliveryeffect of system parameters on controlled release drug delivery
effect of system parameters on controlled release drug delivery
HamedBarzeh
 
Diffusion parameters liki
Diffusion parameters likiDiffusion parameters liki
Diffusion parameters liki
likuradhe
 
HECKEL PLOT CEUTICS .pptx
HECKEL PLOT CEUTICS .pptxHECKEL PLOT CEUTICS .pptx
HECKEL PLOT CEUTICS .pptx
AbdulNaim14
 
Dissolution f1 and f2 Analysis and IVIVC
Dissolution f1 and f2 Analysis and IVIVCDissolution f1 and f2 Analysis and IVIVC
Dissolution f1 and f2 Analysis and IVIVC
Cipla Pharmaceuticals
 
Dissolution models
Dissolution modelsDissolution models
Dissolution models
supriyawable1
 
Similarity and difference factors of dissolution
Similarity and difference factors of dissolutionSimilarity and difference factors of dissolution
Similarity and difference factors of dissolution
Jessica Fernandes
 
Pharmacokinetics / Biopharmaceutics - Multi compartment IV bolus
Pharmacokinetics / Biopharmaceutics - Multi compartment IV bolusPharmacokinetics / Biopharmaceutics - Multi compartment IV bolus
Pharmacokinetics / Biopharmaceutics - Multi compartment IV bolus
Areej Abu Hanieh
 
applicationsofdrugreleasedata-130212133522-phpapp01
applicationsofdrugreleasedata-130212133522-phpapp01applicationsofdrugreleasedata-130212133522-phpapp01
applicationsofdrugreleasedata-130212133522-phpapp01
Vikas Aggarwal
 
TOXICOKINETICS
TOXICOKINETICSTOXICOKINETICS
TOXICOKINETICS
Koppala RVS Chaitanya
 

Similar to Dissolution model.pptx (20)

Modeling and comparison of dissolution profiles - Review by Paulo Costa*, Jos...
Modeling and comparison of dissolution profiles - Review by Paulo Costa*, Jos...Modeling and comparison of dissolution profiles - Review by Paulo Costa*, Jos...
Modeling and comparison of dissolution profiles - Review by Paulo Costa*, Jos...
 
Consolidation parameters
Consolidation parametersConsolidation parameters
Consolidation parameters
 
DRUG RELEASE KINETICS AND MATHEMATICAL MODELLING.pptx
DRUG RELEASE KINETICS AND MATHEMATICAL MODELLING.pptxDRUG RELEASE KINETICS AND MATHEMATICAL MODELLING.pptx
DRUG RELEASE KINETICS AND MATHEMATICAL MODELLING.pptx
 
Consolidation parameters
Consolidation parametersConsolidation parameters
Consolidation parameters
 
Dissolution models (sem 1)
Dissolution models (sem 1)Dissolution models (sem 1)
Dissolution models (sem 1)
 
DISSOLUTION AND MECHANISM OF DRUG RELEASE
 DISSOLUTION AND MECHANISM OF DRUG RELEASE DISSOLUTION AND MECHANISM OF DRUG RELEASE
DISSOLUTION AND MECHANISM OF DRUG RELEASE
 
Consolidation parameter
Consolidation parameterConsolidation parameter
Consolidation parameter
 
Consolidation parameter
Consolidation parameterConsolidation parameter
Consolidation parameter
 
invito release models.pptx
invito release models.pptxinvito release models.pptx
invito release models.pptx
 
Kinetic models
Kinetic modelsKinetic models
Kinetic models
 
Dissolution kinetics and dissolutition modesl
Dissolution kinetics and dissolutition modeslDissolution kinetics and dissolutition modesl
Dissolution kinetics and dissolutition modesl
 
effect of system parameters on controlled release drug delivery
effect of system parameters on controlled release drug deliveryeffect of system parameters on controlled release drug delivery
effect of system parameters on controlled release drug delivery
 
Diffusion parameters liki
Diffusion parameters likiDiffusion parameters liki
Diffusion parameters liki
 
HECKEL PLOT CEUTICS .pptx
HECKEL PLOT CEUTICS .pptxHECKEL PLOT CEUTICS .pptx
HECKEL PLOT CEUTICS .pptx
 
Dissolution f1 and f2 Analysis and IVIVC
Dissolution f1 and f2 Analysis and IVIVCDissolution f1 and f2 Analysis and IVIVC
Dissolution f1 and f2 Analysis and IVIVC
 
Dissolution models
Dissolution modelsDissolution models
Dissolution models
 
Similarity and difference factors of dissolution
Similarity and difference factors of dissolutionSimilarity and difference factors of dissolution
Similarity and difference factors of dissolution
 
Pharmacokinetics / Biopharmaceutics - Multi compartment IV bolus
Pharmacokinetics / Biopharmaceutics - Multi compartment IV bolusPharmacokinetics / Biopharmaceutics - Multi compartment IV bolus
Pharmacokinetics / Biopharmaceutics - Multi compartment IV bolus
 
applicationsofdrugreleasedata-130212133522-phpapp01
applicationsofdrugreleasedata-130212133522-phpapp01applicationsofdrugreleasedata-130212133522-phpapp01
applicationsofdrugreleasedata-130212133522-phpapp01
 
TOXICOKINETICS
TOXICOKINETICSTOXICOKINETICS
TOXICOKINETICS
 

More from RajdeepaKundu

Self-nano emulsifying drug delivery systems.pptx
Self-nano emulsifying drug delivery systems.pptxSelf-nano emulsifying drug delivery systems.pptx
Self-nano emulsifying drug delivery systems.pptx
RajdeepaKundu
 
Construction and working of silverson emulsifier
Construction and working of silverson emulsifierConstruction and working of silverson emulsifier
Construction and working of silverson emulsifier
RajdeepaKundu
 
Application of buffers,buffers equation and buffer capacity
Application of buffers,buffers equation and buffer capacityApplication of buffers,buffers equation and buffer capacity
Application of buffers,buffers equation and buffer capacity
RajdeepaKundu
 
Suppositories the semi solid dosage form
Suppositories the semi solid dosage formSuppositories the semi solid dosage form
Suppositories the semi solid dosage form
RajdeepaKundu
 
Alpha-amylase inhibitors: alternative approach for the treatment of type 2 di...
Alpha-amylase inhibitors: alternative approach for the treatment of type 2 di...Alpha-amylase inhibitors: alternative approach for the treatment of type 2 di...
Alpha-amylase inhibitors: alternative approach for the treatment of type 2 di...
RajdeepaKundu
 
Nanocarrier based strategies for eye cancer management and
Nanocarrier based strategies for eye cancer management andNanocarrier based strategies for eye cancer management and
Nanocarrier based strategies for eye cancer management and
RajdeepaKundu
 
Nanocarriers role in eye cancer treatment and management
Nanocarriers role in eye cancer treatment and managementNanocarriers role in eye cancer treatment and management
Nanocarriers role in eye cancer treatment and management
RajdeepaKundu
 

More from RajdeepaKundu (7)

Self-nano emulsifying drug delivery systems.pptx
Self-nano emulsifying drug delivery systems.pptxSelf-nano emulsifying drug delivery systems.pptx
Self-nano emulsifying drug delivery systems.pptx
 
Construction and working of silverson emulsifier
Construction and working of silverson emulsifierConstruction and working of silverson emulsifier
Construction and working of silverson emulsifier
 
Application of buffers,buffers equation and buffer capacity
Application of buffers,buffers equation and buffer capacityApplication of buffers,buffers equation and buffer capacity
Application of buffers,buffers equation and buffer capacity
 
Suppositories the semi solid dosage form
Suppositories the semi solid dosage formSuppositories the semi solid dosage form
Suppositories the semi solid dosage form
 
Alpha-amylase inhibitors: alternative approach for the treatment of type 2 di...
Alpha-amylase inhibitors: alternative approach for the treatment of type 2 di...Alpha-amylase inhibitors: alternative approach for the treatment of type 2 di...
Alpha-amylase inhibitors: alternative approach for the treatment of type 2 di...
 
Nanocarrier based strategies for eye cancer management and
Nanocarrier based strategies for eye cancer management andNanocarrier based strategies for eye cancer management and
Nanocarrier based strategies for eye cancer management and
 
Nanocarriers role in eye cancer treatment and management
Nanocarriers role in eye cancer treatment and managementNanocarriers role in eye cancer treatment and management
Nanocarriers role in eye cancer treatment and management
 

Recently uploaded

CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
arahmanzai5
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
rightmanforbloodline
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
bkling
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
Swastik Ayurveda
 

Recently uploaded (20)

CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
 

Dissolution model.pptx

  • 1. Dissolution Model Presented by- Rajdeepa Kundu(JISU/2022/0198) Batch-M.Pharm 1st year Pharmaceutics Under the guidance of – Dr Tapan Kumar Shaw (Associate professor of JIS university)
  • 2. Dissolution • According to the IUPAC,the term “dissolution” is defined as “The mixing of two phases with the formation of one new homogeneous phase (i.e. the solution).” • The “dissolution rate” of a drug in a liquid is generally defined as the change in the concentration of dissolved drug (individualized drug molecules/ions/atoms), dc, in the time interval dt: • dissolution rate = dc/ dt
  • 3. 5 major steps involved in the dissolution of solid drug particles in a well-stirred aqueous medium • The surface of the drug particle is wetted with water. • (b) Solid-state bonds in the drug particle are broken down (e.g. attractive electrostatic forces in a drug crystal consisting of cations and anions). • (c) Individualized drug molecules/ions/atoms are surrounded by a shell of water molecules (“solvation”). (d) The individualized drug molecules/ions/atoms diffuse from the surface of the drug particle through the liquid, unstirred boundary layer surrounding the system into the well-stirred bulk fluid. It has to be pointed out that even in thoroughly stirred aqueous liquids thin unstirred boundary layers exist directly at the surfaces of the drug particles (due to adhesional forces). The thickness of these boundary layers is a function of the degree of agitation. • (e) If the surrounding bulk fluid is well-stirred, the drug molecules/ions/atoms are transported by convection in the liquid, which is not part of the unstirred boundary layer: The mass flow created by stirring assures rapid movement of water and
  • 4. Modeling of dissolution profiles A water-soluble drug incorporated in a matrix is mainly released by diffusion, while for a low water-soluble drug the self-erosion of the matrix will be the principal release mechanism. • To accomplish these studies the cumulative profiles of the dissolved drug are more commonly used. • To compare dissolution profiles between two drug products model dependent (curve fitting), statistic analysis and model independent methods can be used. Mathematical models: • Zero order kinetics • First-order kinetics • Weibull model • Higuchi model • Hixson–Crowell model • Korsmeyer–Peppas model • Baker–Lonsdale model • Hopfenberg model • Other release parameters
  • 5. Zero-order kinetics Drug dissolution from pharmaceutical dosage forms that do not disaggregate and release the drug slowly (assuming that area does not change and no equilibrium conditions are obtained) can be represented by the following equation. The pharmaceutical dosage forms following this profiles release the same amount of drug by unit of time and it is the ideal method of drug release in order to achieve a pharmacological prolonged action. • W0 – Wt = Kt , where W0 is the initial amount of drug in the pharmaceutical dosage form, Wt is the amount of drug dissolved at time t and K is a proportionality constant. Applications: This relation can be used to describe the drug dissolution of several types of modified release pharmaceutical dosage forms, as in the case of some transdermal systems, as well as matrix tablets with low soluble drugs, coated forms, osmotic systems, etc
  • 6. First-order kinetics This model was first proposed by Gibaldi and Feldman (1967) and later by Wagner (1969). The dissolution phenomena of a solid particle in a liquid media implies a surface action, as can be seen by Noyes–Whitney Equation: dC/dt = K(Cs –C),where C is the concentration of the solute in time t, Cs is the solubility and K is a first order proportionality constant. This equation was altered by Brunner et al. (1900), to incorporate the value of the solid area accessible to dissolution, S, getting: dC/dt = K1 S(Cs-C), Where, k1 is a new proportionality constant. Using the Fick first law, it is possible to establish the following relation ,for the constant k1 = D/Vh , where D is the solute diffusion coefficient in the dissolution media, V is the liquid dissolution volume and h is the width of the diffusion layer.
  • 7. Continue… Hixson and Crowell adapted the Noyes–Whitney equation in the following manner: dW/dt = kS(Cs-C), where W is the amount of solute in solution at time t, dW/dt is the passage rate of the solute into solution in time t and K is a constant. This last equation is obtained from the Noyes–Whitney equation by multiplying both terms of equation by V and making K equal to k V. Comparing these terms, the following relation is obtained: • K= D/h In this manner, Hixson and Crowell equation can be written as:dW/ dt = KS/V (VCs-W) = k (VCs-W),Where k = k1S. If one pharmaceutical dosage form with constant area is studied in ideal conditions (sink conditions), it is possible to use this last equation that, after integration, will become: W = VCs (1 – e -kt) .This equation can be transformed, applying decimal logarithms in both terms, into: Log (VCs- W) = log VCs- (kt/2.303), The data obtained are plotted as log cumulative percentage of drug remaining vs. time which would yield a straight line with a slope of-K/2.303 Applications: This relationship can be used to describe drug dissolution in pharmaceutical dosage forms such as those containing water-soluble drugs in porous matrices.
  • 8. Hixson– Crowell model Drug powder that having uniformed size particles, Hixson and Crowell derived the equation which expresses rate of dissolution based on cube root of weight of particles and the radius of particle is not assumed to be constant. This is expressed by the equation, M0 1/3 - Mt 1/3 = κ t ,Where, M0 is the initial amount of drug in the pharmaceutical dosage form, Mt is remaining amount of drug in the pharmaceutical dosage form at time ‘t’ and κ is proportionality constant. To study the release kinetics, data obtained from in vitro drug release studies were plotted as cube root of drug percentage remaining in matrix versus time Applications: This applies to different pharmaceutical dosage forms such as tablets, where the dissolution occurs in planes parallel to the drug surface if the tablet dimensions diminish proportionally, in such a way that the initial geometrical form keeps constant all the time. Cube root law- The dissolution data are plotted in accordance with the Hixson-Crowell cube root law, i.e. the cube root of the initial concentration minus the cube root of per cent remained, as a function of time. The results indicates that a linear relationship was obtained in all cases.
  • 9. Higuchi model This is the first mathematical model that describes drug release from a matrix system, proposed by Higuchi in 1961. This model is based on the different hypotheses that (1) Initial drug concentration in the matrix is much higher than drug solubility, (2) Drug diffusion takes place only in one dimension (Edge effect should be avoided), (3) Drug particles are much smaller than thickness of system, (4) swelling of matrix and dissolution are less or negligible, (5) Drug diffusivity is constant, (6) Perfect sink condition is always attained in the release environment. Equation-ft = Q = √D(2C-Cs )Cs t , where Q is the amount of drug released in time t per unit area, C is the drug initial concentration, Cs is the drug solubility in the matrix media and D is the diffusivity of the drug molecules (diffusion constant) in the matrix substance. Higuchi describes drug release as a diffusion process based in Fick’s law, square root time dependent. The data obtained were plotted as cumulative percentage drug release versus square root of time Applications: This relationship can be used to describe the drug dissolution from several types of modified-release pharmaceutical dosage forms, as in the case of some transdermal systems and matrix tablets with water-soluble drugs.
  • 10. Korsmeyer– Peppas model Nicholas Peppas was the first to introduce this equation in the field of drug delivery (Peppas, 1985). Clearly, the classical Higuchi equation as well as the above-described short time approximation of the exact solution of Fick’s second law for thin films with initial drug concentrations, which are below drug solubility (monolithic solutions) Frequently used and easy-to-apply model to describe drug release Peppas equation, or power law: Mt/M∞= kt n , Here, Mt and M∞ are the absolute cumulative amount of drug released at time t and infinite time, respectively; k is a constant incorporating structural and geometric characteristics of the system, and n is the release exponent, which might be indicative of the mechanism of drug release. Used when a release exponent of 0.5 can serve as an indication for diffusion-controlled assumptions drug release, but only if all these particular solutions are based on are fulfilled, for example film geometry with negligible edge effects, time- and position- independent diffusion coefficients in a non-swellable and insoluble matrix former Applications: This equation has been used to the linearization of release data from several formulations of microcapsules or microspheres.
  • 11.
  • 12. Comparison of dissolution profiles The drug-release profiles can be analyzed using the f2 metrics mathematical equation that compares drug-release curves. • f2 metric is the similarity factor, and values of f2 between 50 and 100 suggest profile similarity. A value less than 50 represents a significant difference and equates to a greater than 10% dissolved difference between the two drug-release curves. • Rt represents the reference profile, Tt represents the test profile where (n) is the number of data points collected. Equation: Difference factor(F1) Similarity factor(F2) innference 0 100 Dissolution profile are similar <=15 50 Similarity or equivalenc e of 2 profile
  • 13. Reference Cartensen JT; Modeling and data treatment in the pharmaceutical sciences. Technomic Publishing Co. Inc., New York, Basel 1996 Ramteke KH, Dighe PA, Kharat AR, Patil SV. Mathematical models of drug dissolution: a review. Sch. Acad. J. Pharm. 2014 Jan;3(5):388-96. 2014